This is an index of side effect / adverse reaction reports (a.k.a. adverse event reports) related to Orap (Pimozide) and submitted to the FDA during the sample period of about a year. The information is not vetted and should not be considered as verified clinical evidence.
Reports by Event Outcome
All Cases (9)
Reports by Reaction Type
Fear (3),
Suicidal Ideation (3),
Depression (3),
Anxiety (3),
Rhabdomyolysis (2),
Inappropriate Antidiuretic Hormone Secretion (2),
Vomiting (2),
Hyponatraemia (2),
Diarrhoea (2),
Abdominal Pain (1),
Blood Creatine Phosphokinase Increased (1),
Therapeutic Response Unexpected (1)
Possible Orap side effects in female
Reported by a health professional (non-physician/pharmacist) from Denmark on 2012-08-14
Patient: female
Reactions: Ventricular Extrasystoles, Dystonia, Multiple Drug Overdose
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Escitalopram
Dosage: one intake of 10 tab. of 10 mg
Administration route: Oral
Start date: 2012-04-30
End date: 2012-04-30
Orap
Dosage: one intake of 10 tab. of 1 mg
Administration route: Oral
Start date: 2012-04-30
End date: 2012-04-30
Paroxetine
Dosage: one intake of 2 tab. of 20 mg
Administration route: Oral
Start date: 2012-04-30
End date: 2012-04-30
Possible Orap side effects in female
Reported by a consumer/non-health professional from United States on 2012-05-23
Patient: female, weighing 98.5 kg (216.7 pounds)
Reactions: Anxiety, Fear, Depression, Suicidal Ideation
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Orap
Dosage: 4 milligram;
Administration route: Oral
Indication: Tourette's Disorder
Start date: 1985-01-01
End date: 2012-03-01
Orap
Dosage: 2 milligram;
Administration route: Oral
Start date: 1985-01-01
End date: 1995-01-01
Possible Orap side effects in 16 year old female
Reported by a physician from Denmark on 2012-04-23
Patient: 16 year old female, weighing 64.0 kg (140.8 pounds)
Reactions: Blood Creatine Phosphokinase Increased, Aspartate Aminotransferase Increased, Acute Psychosis, Neuroleptic Malignant Syndrome, Stupor, Leukocytosis
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Ziprasidone Hydrochloride
Dosage: 80 mg
End date: 2012-03-23
Zyprexa
Dosage: 10 mg, as needed
Administration route: Oral
Indication: Psychotic Disorder
Start date: 2012-02-24
End date: 2012-03-23
Ziprasidone Hydrochloride
Dosage: 40 mg, 2x/day
Administration route: Oral
Indication: Psychotic Disorder
Start date: 2010-01-01
End date: 2012-03-23
Ziprasidone Hydrochloride
Dosage: 60 mg
Orap
Dosage: dose 2 mg, strength 1 mg
Administration route: Oral
Indication: Tourette's Disorder
Start date: 2007-01-01
End date: 2012-03-23
Other drugs received by patient: Clonidine; Topamax
Possible Orap side effects in female
Reported by a consumer/non-health professional from United States on 2012-04-13
Patient: female, weighing 98.5 kg (216.7 pounds)
Reactions: Anxiety, Depression, Suicidal Ideation
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Orap
Dosage: 4 milligram;
Administration route: Oral
Indication: Tourette's Disorder
Start date: 1985-01-01
End date: 2012-03-01
Orap
Dosage: 2 milligram;
Administration route: Oral
Start date: 1985-01-01
End date: 1995-01-01
Possible Orap side effects in 59 year old female
Reported by a consumer/non-health professional from United States on 2012-04-10
Patient: 59 year old female, weighing 98.4 kg (216.5 pounds)
Reactions: Anxiety, Refusal of Treatment by Patient, Fear, Condition Aggravated, Tourette's Disorder
Drug(s) suspected as cause:
Haldol
Dosage: 5 mg;qd;po
Administration route: Oral
Indication: Tourette's Disorder
Start date: 2012-03-28
Pimozide (NO Pref. Name)
Dosage: 4 mg;qd;po
Administration route: Oral
End date: 2012-03-01
Orap
Dosage: 2 mg;qd;po
Administration route: Oral
Indication: Tourette's Disorder
Start date: 1985-01-01
Orap
Dosage: 2 mg;qd;po
Administration route: Oral
Indication: Condition Aggravated
Start date: 1985-01-01
Benztropine Mesylate
Dosage: ;qd or bid;
Indication: Adverse Event
Start date: 2012-01-01
End date: 2012-01-01
Possible Orap side effects in female
Reported by a consumer/non-health professional from United States on 2012-04-09
Patient: female, weighing 98.5 kg (216.7 pounds)
Reactions: Depression, Suicidal Ideation
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Orap
Dosage: 2 milligram;
Administration route: Oral
Start date: 1985-01-01
End date: 1995-01-01
Orap
Dosage: 4 milligram;
Administration route: Oral
Indication: Tourette's Disorder
Start date: 1985-01-01
End date: 2012-03-01
Possible Orap side effects in female
Reported by a consumer/non-health professional from United States on 2012-03-30
Patient: female
Reactions: Abdominal Pain, Therapeutic Response Unexpected, Fear, Dyskinesia
Drug(s) suspected as cause:
Orap
Administration route: Oral
Indication: Tourette's Disorder
Benztropine Mesylate
Possible Orap side effects in 45 year old female
Reported by a health professional (non-physician/pharmacist) from France on 2011-10-13
Patient: 45 year old female
Reactions: Vomiting, Rhabdomyolysis, Diarrhoea, Inappropriate Antidiuretic Hormone Secretion, Hyponatraemia
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Orap
Dosage: unk
Administration route: Oral
Zoloft
Dosage: unk
Administration route: Oral
Other drugs received by patient: Trihexyphenidyl Hydrochloride; Milligynon
Possible Orap side effects in 45 year old female
Reported by a health professional (non-physician/pharmacist) from France on 2011-10-05
Patient: 45 year old female
Reactions: Rhabdomyolysis, Vomiting, Diarrhoea, Inappropriate Antidiuretic Hormone Secretion, Hyponatraemia
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Zoloft
Administration route: Oral
Orap
Administration route: Oral
Other drugs received by patient: Milligynon; Trihexyphenidyl Hydrochloride
|